TAPP analogs containing β3-homo-amino acids: Synthesis and receptor binding

Journal of Peptide Science

Volumn 18, Issue 9, 2012, Pages 556-559

  Podwysocka, D ^a,c   Kosson, P ^b   Lipkowski, A W ^b   Olma, Aleksandra ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c Polpharma SA   (Poland)

Author keywords

, hybrids of opioid peptides; 3 homo amino acid; opioid agonist peptides; Radioligand binding; Tetrapeptide TAPP analogs

Indexed keywords

BETA AMINO ACID; DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR; TETRAPEPTIDE AMIDE; TYROSINE BETA3 HOMO DEXTRO ALANYLPHENYLALANYLPHENYLALANINAMIDE; TYROSINE DEXTRO ALANYLPHENYLALANYLPHENYLALANINAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; DRUG CONFORMATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS; RECEPTOR AFFINITY; STRUCTURE ANALYSIS;

AMINO ACIDS; OLIGOPEPTIDES; OPIOID PEPTIDES; PROTEIN BINDING; RECEPTORS, OPIOID;

EID: 84865192796     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2433     Document Type: Article

References (23)

1. Ciccone PE, O'Brien CP, Khatami M. Psychotropic agents in opiate addiction: a brief review. Int. J. Addict. 1980; 15: 499-513.
2. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293: 311-315.
3. Moles A, Kieffer BL, D'Amato FR. Deficit in attachment behavior in mice lacking the [mu]-opioid receptor gene. Science 2004; 304: 1983-1986.
4. Jaglowski JR, Zagon IS, Stack Jr. BC, Verderame MF, Aeure-duPree AE, Manning JD, McLaughlin PJ. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck. Cancer Chemother. Pharmacol. 2005; 56: 97-104.
5. Lazarczyk M, Matyja E, Lipkowski AW. A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro. Peptides 2010; 31: 1606-1612.
6. Yakovleva T, Marinova Z, Kuzmin A, Seidah NG, Haroutunian V, Terenius L, Bakalkin G. Dysregulation of dynorphins in Alzheimer disease. Neurobiol. Aging 2007; 28: 1700-1708.
7. Varrassi G, Angeletti C, Guetti C, Marinangeli F, Paladini A. Systemic opioid and chronic pain. Eur. J. Pain Suppl. 2009; 3: 77-83.
8. Moulédous L, Mollereau C, Zajac J-M. Opioid-modulating properties of the neuropeptide FF system. Biofactors 2010; 36: 423-429.
9. Kieffer BL, Gavériaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 2002; 66: 285-306.
10. Schiller PW, Nguyen TM-D, Chung NN, Lemieux C. Dermorphin analogues carrying an increased positive net charge in their 'message' domain display extremely high mu opioid receptor selectivity. J. Med. Chem. 1989; 32: 698-703.
11. Cardillo G, Gentilucci L, Tolomelli A, Calienni M, Qasem AR, Spampinato S. Stability against enzymatic hydrolysis of endomorphin-1 analogues containing β-proline. Org. Biomol. Chem. 2003; 1: 1498-1502.
12. Krondahl E, Orzechowski A, Ekström G, Lennernäs H. Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats. Pharm. Res. 1997; 14: 1780-1785.
13. Zadina JE, Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997; 386: 499-502.
14. 3-homo-amino acids. J. Pept. Sci. 2009; 15: 777-782.
15. 3-homophenylalanine. In Peptides Rolka K, Rekowski P, Silbering J. (eds.) Kenes International: Geneva, Switzerland, 2007; 364-365.
16. Linder MR, Steurer S, Podlech J. (S)-3-(tert-Butyloxycarbonylamino)-4-phenylbutanoic acid. Org. Synth. 2002; 79: 154-159.
17. Koch K, Podlech J. Exceptionally simple homologation of protected α- to β-amino acids in the presence of silica gel. Synth. Comm. 2005; 35: 2789-2794.
18. Seebach D, Ciceri P E, Overhand M, Jaw B, Rigo D. Probing the helical secondary structure of short-chain-peptides. Helv. Chim. Acta 1996; 79: 2043-2066.
19. Gademann K, Ernst M, Seebach D. The cyclo-β-tetrapeptide (β-HPhe-β-HThr-β-HLys-β-HTrp): synthesis, NMR structure in methanol solution, and affinity for human somatostatin receptors. Helv. Chim. Acta 2000; 83: 16-33.
20. Misicka A, Lipkowski AW, Horvat R, Davis P, Kramer TH, Yamamura HI, Hruby VJ. Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin. Life Sci. 1992; 51: 1025-1032.
21. Cardillo G, Gentilucci L, Qasem A R, Sgarzi F, Spampinato S. Endomorphin-1 analogues containing β-proline are μ-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance. J. Med. Chem. 2002; 45: 2571-2578.
22. Keresztes A, Szucs M, Borics A, Kövér KE, Forró E, Fülöp F, Tömböly C, Péter A, Páhi A, Fábián G, Murányi M, Tóth G. New endomorphin analogues containing alicyclic beta-amino acids: influence on bioactive conformation and pharmacological profile. J. Med. Chem. 2008; 51: 4270-4279.
23. Staniszewska R, Fichna J, Gach K, Toth G, Poels J, Vanden Broeck J, Janecka A. Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2. Chem. Bio. Drug Des. 2008; 72: 91-94.